HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.

Abstract
Transduction of malignant glioma with adenovirus serotype 5 (Ad5) vectors is limited by the low levels of coxsackievirus and adenovirus receptor (CAR) on tumor cells. However, malignant brain tumors have been found to overexpress a glioma-associated receptor, interleukin-13 receptor alpha2 chain (IL-13Ralpha2), a marker of both glial transformation and tumor grade. To selectively target Ad5 to IL-13Ralpha2, we constructed a replication-deficient adenoviral vector that possesses an IL-13 ligand presented by a T4 phage fibritin shaft, and designated the new virus LU-13. Western blot and sequence analyses confirmed proper trimerization and ligand presentation by the T4 fibritin shaft. Confocal microscopy analysis of primary glioma suspensions incubated with viral recombinants showed that LU-13 colocalized with IL-13Ralpha2. Luciferase transduction assays conducted in both primary and passaged glioma cell cultures exhibited at least 10-fold enhanced gene transduction. Moreover, the virus preferentially bound to glioma cells, as documented by increased adenoviral E4 DNA copy number. In vitro competition assays performed with anti-human IL-13 monoclonal antibody confirmed significant attenuation of LU-13 transduction. These results were further confirmed in vivo, where LU-13 showed a 300-fold increase in transgene expression. In summary, we describe here the development of a novel and targeted adenoviral vector that binds IL-13Ralpha2. Our findings confirm the ability of LU-13 to bind IL-13Ralpha2 and increase transgene expression, making it an attractive gene therapy vector for the treatment of malignant glioma in a clinical setting.
AuthorsIlya V Ulasov, Matthew A Tyler, Yu Han, Joel N Glasgow, Maciej S Lesniak
JournalHuman gene therapy (Hum Gene Ther) Vol. 18 Issue 2 Pg. 118-29 (Feb 2007) ISSN: 1043-0342 [Print] United States
PMID17328684 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Recombinant
  • Interleukin-13
  • Interleukin-13 Receptor alpha2 Subunit
  • Viral Proteins
  • fibritin protein, Enterobacteria phage T4
Topics
  • Adenoviridae (genetics, metabolism)
  • Animals
  • DNA, Recombinant (genetics, metabolism)
  • Genetic Engineering
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Glioma (genetics, metabolism, therapy)
  • Humans
  • Interleukin-13 (metabolism)
  • Interleukin-13 Receptor alpha2 Subunit (metabolism)
  • Male
  • Mice
  • Mice, Nude
  • Microscopy, Confocal
  • Reproducibility of Results
  • Transduction, Genetic
  • Transgenes
  • Viral Proteins (metabolism)
  • Virus Replication
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: